Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 13,670
+290 (2.17%)
At close: Dec 5, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 164.30 billion as of December 5, 2025. Its market cap has decreased by -24.06% in one year.
Market Cap
164.30B
Enterprise Value
246.96B
Revenue
14.41B
Ranking
n/a
PE Ratio
52.10
Stock Price
13,670.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 164.30B, a decrease of -54.43%. That is a compound annual growth rate of -15.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 164.30B | -9.53% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 6,753.15B |
| Peptron | 6,645.44B |